Higher dose prostate radiation with MRI guidance
Part of Cancer, Kidney & urinary clinical trials.
This study tests a higher dose of radiation for prostate cancer using an MRI-guided machine (MR-Linac). It aims to see if a more targeted dose can be safely given to the tumor while protecting healthy tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 18 or older
- You have prostate cancer that has not spread beyond the prostate (stage T2 or less on MRI)
- Your Gleason score is 3+3, 3+4, or 4+3 (Grade groups 1, 2, or 3)
- Your PSA is less than 20 ng/mL (if you are taking hormone therapy, that's okay)
- You are able to have an MRI and do not have a pacemaker, metal implants, or severe claustrophobia
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if giving fewer radiation treatments using a special MRI-guided machine is safe and effective for men with prostate cancer. It may help reduce side effects while still controlling the cancer.
This trial tests a newer way to plan and deliver radiation for prostate cancer using real-time MRI guidance. It may help by aiming high-dose treatment precisely while treating nearby disease and (in some cases) limited metastatic spots.
This trial tests whether using MRI scans to guide radiation can allow lower doses to the healthy parts of the prostate, potentially reducing side effects. It is for men with intermediate- or high-risk prostate cancer that can be seen on MRI and has not spread.
This study tests whether adding a stronger, focused radiation “boost” to a visible prostate spot—using real-time MRI guidance—can improve treatment for locally advanced prostate cancer. It may help better control the tumor while still delivering standard radiation to the rest of the prostate area.
This trial tests a stronger, more focused radiation dose to the main tumor inside the prostate using MRI guidance. It aims to improve control of intermediate-risk prostate cancer while possibly reducing side effects.
This study tests radiation treatment planned and guided using MRI scans (“image-guided radiotherapy”) for men with prostate cancer who are aiming for a cure. If you qualify, you may receive radiation with more precise targeting using MRI to help deliver treatment accurately.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.